Journal articleHum Cell2022
Lipocalin-2 inhibits pancreatic cancer stemness via the AKT/c-Jun pathway.
- Journal
- Hum Cell
- Published
- 6 July 2022
- Citations
- 5
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Cancer stem cells (CSCs) are involved in cancer recurrence and metastasis owing to their self-renewal properties and drug-resistance capacity. Lipocalin-2 (Lcn2) of the lipocalin superfamily is highly expressed in pancreatic cancer. … Excerpt only: this text is the publisher’s. Read it in full at the source.